MindMaze Therapeutics Holding SA
MMTZF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001854078
No open-market purchases or sales by MindMaze Therapeutics Holding SA insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $19 in total; no superinvestor holds it.
Other share classesRLFTY
Q1 2024 vs. Q4 2023
How the institutions holding MindMaze Therapeutics Holding SA changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 1 | 1 | 1 | +1 |
| Shares | 12 | 12 | 77 | +77 |
| Value | $28 | $28 | $111 | +$111 |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held MindMaze Therapeutics Holding SA at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Horizon Financial Services, LLC | 77 | $111 | 0.00% |
Sold out (0)
Institutions that held MindMaze Therapeutics Holding SA at the end of Q4 2023 and filed for Q1 2024 without it.
None.
Not filed for Q1 2024 yet (1)
Institutions that held MindMaze Therapeutics Holding SA at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Strategic Investment Solutions, Inc. | 12 | $28 |